G Taçoy

Do the Different Types of Pulmonary Hypertension Cause the Same Effect on Right Heart and Serum Asymmetrıcal Dimethylarginine Levels in Female Patients?

Issue:

Vol 69, Issue 1: 2021

DOI:

10.7727/wimj.2015.319

Pages:

26-31

Synopsis:

This study aimed to evaluate if the different types of pulmonary hypertension had the same effect on right-heart functions and serum asymmetric dimethylarginine levels in female patients. It was found that pulmonary arterial hypertension caused more impaired right-heart functions than pulmonary venous hypertension.

ABSTRACT

Objective: Right-heart function is a major determinant of clinical outcome in patients with elevated pulmonary artery pressure due to pulmonary venous hypertension (PVH) and pulmonary arterial hypertension (PAH). Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase. This study aimed to evaluate if different types of pulmonary hypertension (PH) would cause the same effect on right-heart functions and serum ADMA levels in female patients.

Received:

17 Jun, 2015

Accepted:

23 Nov, 2015

Published:

30 Apr, 2021

PDF Attachment:

wimj-iss1-2021_26_31.pdf

Journal Sections:

Original Articles

Keywords:

Asymmetric dimethylarginine

Echocardiography

pulmonary arterial hypertension

pulmonary venous hypertension

right-ventricular fractional area change

Tei index

tricuspid annuler plane systolic excursion

Journal Authors:

e-Published: 14 Mar, 2016

Read more about Do the Different Types of Pulmonary Hypertension Cause the Same Effect on Right Heart and Serum Asymmetrıcal Dimethylarginine Levels in Female Patients?

Combinaton Therapy in Pulmonary Arterial Hypertension: Single Centre Long-term Experience

Issue:

Vol 65, Issue 1: 2016

DOI:

10.7727/wimj.2014.148

Pages:

46–51

Synopsis:

Pulmonary arterial hypertension (PAH) is a progressive disease of the pulmonary vascular bed, and right heart failure is the leading cause of death. Treatment with vasoactive agents is crucial for these patient groups. We aimed to evaluate our treatment approach in patients with PAH patients as a tertiary centre.

ABSTRACT

Received:

17 Jun, 2014

Accepted:

26 Sep, 2014

PDF Attachment:

wimj_iss1_2016_46_51.pdf

Journal Sections:

Original Articles

Keywords:

Hypertension

pulmonary artery